Table 1.
Characteristics of participants who completed initial survey (n = 77)
| Demographic items | Internet First % (n) | Paper First % (n) |
| Total | (38)a | (39) |
| Mean age (standard deviation) | 59 (9.2) | 59 (10.1) |
| Female | 58 (22) | 59 (23) |
| % Caucasian | 97.4 (37) | 94.9 (37) |
| Cancer diagnosis | ||
| Breast | 31.6 (12) | 28.2 (11) |
| Lung | 18.4 (7) | 25.6 (10) |
| Gastrointestinalb | 15.8 (6) | 20.5 (8) |
| Kidney | 10.5 (4) | 10.3 (4) |
| Prostate | 10.5 (4) | 5.1 (2) |
| Ovarian | 5.3 (2) | 7.7 (3) |
| Otherc | 7.9 (3) | 2.6 (1) |
| Cancer status | ||
| Localised | 55.3 (21) | 35.9 (14) |
| Locally advanced/advanced | 5.2 (2) | 7.7 (3) |
| Metastatic/recurrent | 39.5 (15) | 56.4 (22) |
| Treatment | ||
| Single modality | ||
| Surgery only | 31.6 (12) | 20.5 (8) |
| Chemotherapy only | 23.7 (9) | 17.9 (7) |
| Multiple modalities | ||
| Surgery ± radiation and/or chemo | 34.2 (15) | 53.8 (21) |
| Radiation and chemotherapy | 10.5 (4) | 7.7 (3) |
a
One participant with mutually exclusive responses to all items on the paper and Internet surveys was considered noninformative and was excluded from all analysis.
b
Gastrointestinal cancer: oesophageal, colon, pancreatic, rectal, and cholangiocarcinoma.
c
Other cancers: melanoma, thymoma, multiple myeloma, and endometria